Navigation Links
NimbleGen partners with leading researchers

Madison, Wis. - NimbleGen Systems, Inc., a producer of high-density microarrays, is allowing researchers to work with its advanced technology used for studying DNA interactions inside the cell.

The company has announced a number of limited-access partnerships, opening the door for organizations like Yale Univers......

Full article >>> m experiments currently unattainable."

Biological processes, such as transcription and DNA replication, depend on complex but coordinated interactions between proteins and DNA. To understand the mechanisms of such processes and learn about biological development and disease processes and evolution, researchers study how various proteins associate with their specific DNA target sequences i......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 07/24/06


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
3. IPO-bound NimbleGen traveling in fast company
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Genomics researcher Hood joins NimbleGen board
6. NimbleGen partners with UK biotech firm
7. NimbleGen extends research market reach
8. NimbleGen microarrays speed genetic findings
9. NimbleGen names CFO with capital-raising past
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
(Date:10/11/2017)... ... 2017 , ... Disappearing forests and increased emissions are the main causes of ... year. Especially those living in larger cities are affected by air pollution related diseases. ... most pollution-affected countries globally - decided to take action. , “I knew I had ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
Breaking Biology News(10 mins):